Gregory Norden

Gregory Norden is the former Chief Financial Officer of Wyeth and has been a member of our board since January 2013. Mr. Norden also serves on the Boards of NanoString Technologies, a leading provider of life science tools for translational research; Praxis, a clinical stage biopharmaceutical company; and Royalty Pharma, a leading funder of innovation across the biopharmaceutical industry. Mr. Norden is a former director of Human Genome Sciences, Univision, and Welch Allyn. In addition, Mr. Norden is the Managing Director of G9 Capital Group LLC, which invests in early stage ventures and provides corporate finance advisory services.